oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 Most viewed this week from JAMA Internal Medicine: of # daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or # Oral Semaglutide 25 mg Demonstrates

GLP-1 drugs suppress appetite and weight and can drop blood glucose and blood pressure, potentially making surgery outcomes better in the long run

PlushCare doesnt actually hide its feeseverything is clearly spelled out on the websitebut its subscription doesnt cover consultations or lab work

According to CNN, more than 70% of semaglutide prescriptions have gone to White patients White people are about four times more likely than Black people to have a prescription for a semaglutide medication, despite having nearly a 40% lower prevalence of diabetes and a 17% lower prevalence of obesity. So, White patients are receiving the vast majority of semaglutide prescriptions (Ozempic and Wegovy) by percentage, despite having a lower prevalence of both diabetes and obesity

And then unfortunately, like really battled being what one called a fat kid

A doctor can adjust the dose to balance results with side effects

Understanding these factors empowers you to compare treatment options strategically and identify which formulation aligns with your budget and lifestyle